These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6132059)

  • 1. Mucoid gram-negative bacilli in cystic fibrosis.
    Kelly NM; Falkiner FR; Keane CT; Fitzgerald MX; Tempany E
    Lancet; 1983 Mar; 1(8326 Pt 1):705. PubMed ID: 6132059
    [No Abstract]   [Full Text] [Related]  

  • 2. Mucoid Escherichia coli in cystic fibrosis.
    Macone AB; Pier GB; Pennington JE; Matthews WJ; Goldmann DA
    N Engl J Med; 1981 Jun; 304(24):1445-9. PubMed ID: 6785645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
    Marty N; Lapchine L; Pradere J; Dutau G
    Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyocin typing of Pseudomonas aeruginosa.
    Farmer JJ; Herman LG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S43-6. PubMed ID: 4213993
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1975 Dec; 83(6):549-52. PubMed ID: 812334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoid Pseudomonas in cystic fibrosis.
    Pritt B; O'Brien L; Winn W
    Am J Clin Pathol; 2007 Jul; 128(1):32-4. PubMed ID: 17580270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyocine typing of mucoid strains of Pseudomonas aeruginosa isolated from children with cystic fibrosis.
    Williams RJ; Govan JR
    J Med Microbiol; 1973 Aug; 6(3):409-12. PubMed ID: 4199274
    [No Abstract]   [Full Text] [Related]  

  • 8. Pseudomonas aeruginosa mucoid strain. Its significance in adult chest diseases.
    Rivera M; Nicotra MB
    Am Rev Respir Dis; 1982 Nov; 126(5):833-6. PubMed ID: 6816110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Henry RL; Dorman DC; Brown J; Mellis C
    Aust Paediatr J; 1982 Mar; 18(1):43-5. PubMed ID: 6808983
    [No Abstract]   [Full Text] [Related]  

  • 10. Affinity for glycoproteins of bacteria found in the respiratory tract in cystic fibrosis.
    Saggers BA; Lawson D
    J Clin Pathol; 1970 Apr; 23(3):262-5. PubMed ID: 4986935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.
    Steinkamp G; Tümmler B; Malottke R; von der Hardt H
    Arch Dis Child; 1989 Jul; 64(7):1022-8. PubMed ID: 2517000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
    Godard C; Plesiat P; Michel-Briand Y
    Eur J Med; 1993 Feb; 2(2):117-20. PubMed ID: 8258014
    [No Abstract]   [Full Text] [Related]  

  • 14. A composite arginine glucose medium for the characterization of Pseudomonas aeruginosa and other gram negative bacilli.
    Stewart DJ
    J Appl Bacteriol; 1971 Dec; 34(4):779-86. PubMed ID: 5004247
    [No Abstract]   [Full Text] [Related]  

  • 15. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L; Perry JD; Lee J; Oliver M; James AL; De La Foata C; Halimi D; Orenga S; Galloway A; Gould FK
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaerobic bacterial infection in patients with cystic fibrosis.
    Tai A; Ranganath S
    Am J Respir Crit Care Med; 2008 Nov; 178(9):994. PubMed ID: 18945873
    [No Abstract]   [Full Text] [Related]  

  • 18. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of alginate from mucoid strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Russell NJ; Gacesa P
    Antibiot Chemother (1971); 1989; 42():62-6. PubMed ID: 2512847
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.
    Bergan T; Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1975 Dec; 83(6):553-60. PubMed ID: 812335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.